Constellation Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$5.43M Buy
36,228
+700
+2% +$104K 0.99% 16
2015
Q4
$5.77M Buy
35,528
+250
+0.7% +$39.3K 1.08% 15
2015
Q3
$4.88M Buy
35,278
+50
+0.1% +$7.88K 1.01% 16
2015
Q2
$5.41M Buy
35,228
+300
+0.9% +$48.1K 1.03% 15
2015
Q1
$5.58M Buy
34,928
+975
+3% +$154K 1.07% 14
2014
Q4
$5.41M Buy
33,953
+1,075
+3% +$168K 1.1% 15
2014
Q3
$4.62M Buy
32,878
+250
+0.8% +$32.6K 1.03% 17
2014
Q2
$3.86M Sell
32,628
-150
-0.5% -$17.4K 0.89% 21
2014
Q1
$4.04M Buy
32,778
+1,575
+5% +$191K 0.98% 20
2013
Q4
$3.56M Buy
31,203
+2,100
+7% +$239K 0.91% 21
2013
Q3
$3.26M Buy
29,103
+1,900
+7% +$206K 1% 19
2013
Q2
$2.68M Buy
+27,203
New +$2.82M 0.93% 23

Other funds holding AMGN

Constellation Investments's AMGN Position: Q1 2016 in Review

Constellation Investments increased its Amgen (AMGN) stake by 2% in Q1 2016, buying an estimated $104K and bringing the position to 36,228 shares worth $5.43M. The position accounts for 0.99% of the portfolio, ranked #16.

Constellation Investments first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $5.77M in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Constellation Investments held 36,228 shares of Amgen worth $5.43M as of Q1 2016.
  • Constellation Investments bought 700 Amgen shares in Q1 2016, an estimated $104K.
  • Amgen made up 0.99% of Constellation Investments's portfolio in Q1 2016, its #16 holding.
  • Constellation Investments first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
  • Constellation Investments's Amgen position peaked at $5.77M in Q4 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.